Jack Anders - 23 Oct 2023 Form 4 Insider Report for Revolution Medicines, Inc. (RVMD)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
23 Oct 2023, 18:01:14 UTC
Prior SEC filing
20 Sep 2023
Next SEC filing
20 Dec 2023
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Jack Anders

Key filing fact

Jack Anders filed Form 4 for Revolution Medicines, Inc. (RVMD) on 23 Oct 2023.

Key facts

  • This page summarizes Jack Anders's Form 4 filing for Revolution Medicines, Inc. (RVMD).
  • 4 reported transactions and 2 derivative rows are listed below.
  • Accepted by SEC: 23 Oct 2023, 18:01.

Change

  • Previous filing in this sequence was filed on 20 Sep 2023.
  • Current net transaction value: +$72,967.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

RVMD transaction

Common Stock

Options Exercise

Transaction value
$51,957
Shares
+19,387
Change %
+36%
Price
$2.68*
Shares after
73,054
Date
23 Oct 2023
Ownership
Direct
Footnotes
F1
RVMD transaction

Common Stock

Options Exercise

Transaction value
$21,010
Shares
+5,137
Change %
+7%
Price
$4.09*
Shares after
78,191
Date
23 Oct 2023
Ownership
Direct
Footnotes
F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

RVMD transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value
$0
Shares
-19,387
Change %
-46%
Price
$0.000000
Shares after
22,814
Date
23 Oct 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
19,387
Exercise price
$2.68
RVMD transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value
$0
Shares
-5,137
Change %
-100%
Price
$0.000000*
Shares after
0
Date
23 Oct 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
5,137
Exercise price
$4.09
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Includes 40,800 restricted stock units.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .